HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria V Irazabal Selected Research

Hydrogen

3/2020Oxidative Stress and Mitochondrial Abnormalities Contribute to Decreased Endothelial Nitric Oxide Synthase Expression and Renal Disease Progression in Early Experimental Polycystic Kidney Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria V Irazabal Research Topics

Disease

13Autosomal Dominant Polycystic Kidney (ADPKD)
01/2022 - 08/2011
4Polycystic Kidney Diseases (Polycystic Kidney Disease)
03/2020 - 08/2011
3Kidney Diseases (Kidney Disease)
11/2020 - 12/2012
3Disease Progression
03/2020 - 08/2011
3Polycystic liver disease
01/2016 - 09/2012
3Cysts
01/2016 - 08/2011
3Proteinuria
01/2015 - 03/2012
2Fibrosis (Cirrhosis)
01/2020 - 02/2013
2Chronic Renal Insufficiency
01/2020 - 01/2019
2Inflammation (Inflammations)
01/2020 - 02/2013
2Membranous Glomerulonephritis (Membranous Nephropathy)
01/2015 - 01/2013
2Amyloidosis
12/2012 - 01/2012
2Acute Kidney Injury (Acute Renal Failure)
01/2012 - 01/2009
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Vasculitis (Vasculitides)
11/2020
1Cystic Kidney Diseases (Cystic Kidney Disease)
03/2020
1Thrombocytopenia (Thrombopenia)
04/2015
1Anemia
04/2015
1Macrophage Activation Syndrome
04/2015
1Albuminuria
12/2012
1Paraproteinemias (Monoclonal Gammopathy)
12/2012
1Necrosis
12/2012
1Renal Insufficiency (Renal Failure)
03/2012
1Fever (Fevers)
01/2012
1Exanthema (Rash)
01/2012
1Pulmonary Edema
01/2012

Drug/Important Bio-Agent (IBA)

4TolvaptanFDA Link
01/2018 - 08/2011
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
3Rituximab (Mabthera)FDA Link
11/2020 - 01/2013
31-dodecylpyridoxal (PLD)IBA
01/2016 - 09/2012
2Mitochondrial DNA (mtDNA)IBA
01/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020 - 01/2020
2TEMPOIBA
01/2018 - 11/2016
2Octreotide (Sandostatin)FDA LinkGeneric
08/2015 - 09/2012
2Antidiuretic Hormone Receptor AntagonistsIBA
04/2015 - 08/2011
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2015 - 09/2012
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2020
1HydrogenIBA
03/2020
18-hydroxyguanosineIBA
03/2020
1NADPH Oxidases (NAD(P)H oxidase)IBA
03/2020
1NADP (NADPH)IBA
03/2020
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
03/2020
1AntioxidantsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1CreatinineIBA
11/2016
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2016
1diethylstilbestrol monophosphate (PDES)IBA
01/2016
1CalciumIBA
01/2016
1Ferritins (Ferritin)IBA
04/2015
1Angiotensin IIIBA
01/2015
1Monoclonal AntibodiesIBA
01/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2015
1AlbuminsIBA
12/2012
1Cyclic AMP (AMP, Cyclic)IBA
08/2011
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2009

Therapy/Procedure

5Therapeutics
08/2015 - 09/2012
2Stem Cell Transplantation
03/2012 - 01/2012
1Plasma Exchange
11/2020
1Nephrectomy
11/2015
1Investigational Therapies (Experimental Therapy)
02/2013
1Hematopoietic Stem Cell Transplantation
01/2012